ANNIF Financials 07/18/2014 03:57:05
ANNIF Financials 07/18/2014 03:57:05
Annidis Corp
Period Ending
Total Revenue
Cost of Revenue
Gross Profit
Operating Expenses
Research and Development
Sales, General and Admin.
Non-Recurring Items
Other
Operating Income
Income From Continuing Operations
Add'l Income/Expense Items
Earnings Before Interest and Tax
Interest Expense
Earnings Before Tax
Income Tax
Minority Interest
Equity Earnings Unconsolidated Subsidiary
Net Income Cont. Operations
Non Recurring Events
Discontinued Operations
Extraordinary Items
Effect of Accounting Changes
Other Items
Net Income
Preferred Stock and Other Adjustments
Net Income Applicable to Common Shareholders
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Surge in Global Wellness How about this for a shakeup? The global wellness economy isn't just surviving; it's roaring. Clocking in at a staggering $7.5 trillion in 2025, it's set on a straight trajectory to $10.9 trillion by 2030. Talk about making waves! This isn't just some passing fad; it's where money's being funneled fast, and for good reason. Why the Boom? Ever...
Continue Reading
Trading Volumes Surge Amid Economic Shifts You'd think October had a few tricks up its sleeve with how it pulled traders into the game. The 10-year Treasury yield moved up to 5.01%, making folks wonder just how long we'll keep dancing around inflation debates. With the S&P 500 dipping nearly 1% and the Nasdaq Composite spiraling down over 1.5%, investors weren't exactly...
Continue Reading
Clarity Amid Chaos: Handling a Crash in Abilene Let me tell you, if your day starts with a car wreck, every second post-crash counts more than you think. Attorney Chaile Allen out of Abilene's laying down the law on how to protect yourself—because that wreck scene ain't just about bent fenders and bruised egos. It's about getting your ducks in a row for any potential...
Continue Reading
Beyond the Hype: Innovating for Healthier Tomorrows Kicking off in Stockholm on December 1st, the 2026 Prix Galien Bridges Awards isn't just some schmooze-fest; it's a hard-hitting showcase of where true innovation can propel healthcare. Over at the Karolinska Institutet, the Galien Foundation is drawing powerhouses from across the Nordics+ region and showcasing...
Continue Reading
Cracks in the Foundation: CVRx's Turmoil Let me tell you, it's not every day you see a company drop a bombshell on investors like CVRx did, shaking up the ole portfolio right down to its socks. NASDAQ:CVRX has found itself embroiled in a class action lawsuit courtesy of a knotty mix of legal woes, unplanned revenue slashes, and executive shake-ups. A few short years ago,...
Continue Reading
Baijiu Brews Cultural Ties at Melbourne Cup If you thought the Melbourne Cup was only about horse racing, think again. This year, the carnival wasn’t just a playground for the equestrian elite but also a stage for cultural exchange, and Chinese baijiu had its moment to shine. It’s not just about sipping a strong spirit; it's about bridging cultures and building...
Continue Reading
Diving Into Uncharted Waters with Bold Moves MoreBetter is stepping right into the murky, unpredictable world of longevity, peptide, and psychedelic therapies with a fresh initiative—the RWE Co-Investment Program. This isn't your run-of-the-mill study announcement; it's a gutsy leap into largely unexplored areas of patient-reported outcomes and real-world evidence. A...
Continue Reading
Insights for Sellers: The Road to a Smart Sale Alright, here's the deal: you've got a house to sell, and knowing what to fix up beforehand is like playing a high-stakes game of chess. Miss a move, and it could cost you a chunk of change, or worse, a sale. Enter Rosa Stong, the real estate guru from Becker Stong Real Estate Group, dropping knowledge bombs in a HelloNation...
Continue Reading
Curaleaf Gets a Green Light for Acquisition Talk about maneuvering a minefield, eh? Curaleaf Holdings just stamped out the last of its paperwork in the cutthroat cannabis industry to acquire Aurora Cannabis. We're looking at the final sign-offs from not one, but two major players: Germany and Canada's competition authorities. That's no small feat when you're trying to...
Continue Reading
Ampa and Wave Neuroscience Join Forces In a fresh twist on the neurotechnology scene, Ampa's portable TMS system is teaming up with Wave Neuroscience's MeRT to target PTSD. Science and partnership—combined like a decent scotch and a well-done steak, if you ask me. They've got the FDA clearance on their side, and they're bringing it to the clinics without demanding those...
Continue Reading
angout.com/blog/news?page=2">More News Articles